---
schema_version: "secwatch.filing_event.v1"
accession: "0001999371-25-007625"
form_type: "8-K"
ticker: "TNXP"
cik: "0001430306"
company_name: "Tonix Pharmaceuticals Holding Corp."
filed_at: "2025-06-11T23:59:59+00:00"
generated_at: "2026-05-19T12:53:22.644510+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Tonix enters $150M ATM equity facility and $75M Lincoln Park purchase agreement

## Summary
- ATM facility with A.G.P. allows sale of up to $150M in common stock at 3% commission.
- Lincoln Park Purchase Agreement enables up to $75M in stock sales with 97% of VWAP pricing.
- Issued 48,708 commitment shares to Lincoln Park as fee; no upper price limit for purchases.
- Lincoln Park purchases capped at 1,470,703 shares (19.99% of outstanding) unless stockholder approval or price ≥$37.74.
- Proceeds expected for working capital and general corporate purposes; existing shelf registration utilized.

## SEC filing metadata
- accession: 0001999371-25-007625
- form_type: 8-K
- ticker: TNXP
- cik: 0001430306
- company_name: Tonix Pharmaceuticals Holding Corp.
- filed_at: 2025-06-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1430306/000199937125007625/0001999371-25-007625-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1430306/000199937125007625/tnxp-8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001999371-25-007625
- JSON: https://secwatch.observer/filing/0001999371-25-007625.json
- Plain text: https://secwatch.observer/filing/0001999371-25-007625.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.